Browse > Article

Comparison of Serum Insulin, Leptin, Adiponectin and High Sensitivity C-Reactive Protein Levels according to Body Mass Index and their Associations in Adult Women  

Lee, Mi-Young (Department of Food and Nutrition, College of Natural Sciences, Seoul Women's University)
Kim, Jung-Hee (Department of Food and Nutrition, College of Natural Sciences, Seoul Women's University)
Publication Information
Korean Journal of Community Nutrition / v.16, no.1, 2011 , pp. 126-135 More about this Journal
Abstract
Obesity is characterized by increased storage of fatty acids in an adipose tissue and closely associated with the development of insulin resistance and cardiovascular diseases (CVD) through secretion of adipokines. This study was done to compare serum insulin, leptin, adiponectin and high sensitivity C-reactive protein (hs-CRP) levels according to body masss index (BMI) in Korean adult women aged 19 to 50. In addition, we examined the association of BMI, serum lipids and Homa-IR with serum adiponectin, leptin and hs-CRP levels. The subjects were divided into 3 groups by their BMI, normal weight (BMI ${\leq}$ 22.9, n = 30), overweight (23.0 ${\leq}$ BMI ${\leq}$ 24.9, n = 71) and obese group (25.0 ${\leq}$ BMI, n = 59). Serum levels of total-cholesterol, TG, and LDL-cholesterol were significantly higher in obese group than in normal weight group. LDL/HDL ratio and AI were significantly higher in obese group than in normal or overweight group. Fasting serum levels of glucose and insulin and Homa-IR as a marker of insulin resistance were significantly higher in obese group than in overweight group. Serum leptin level was significantly higher in obese group while serum adiponectin level was significantly lower in obese group compared to other two groups. hs-CRP was significantly increased in obese group. Correlation data show that serum adiponectin level was positively correlated with serum HDLcholesterol level and was negatively correlated with BMI, WC, TG, LDL-cholesterol, Homa-IR, hs-CRP and leptin. In addition, serum leptin level was positively correlated with BMI, WC, glucose, insulin, Homa-IR and hs-CRP. These results might imply that the regulation of key adipokines such as adiponectin might be a strategy for the prevention or treatment of obesity-associated diseases such as diabetes and CVD.
Keywords
adiponectin; leptin; hs-CRP; Homa-IR; BMI;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Galic S, Oakhilla JS, Steinberga GR (2010): Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316(2): 129-139   DOI   ScienceOn
2 Steinberg GR, Dyck DJ (2000): Development of leptin resistance in rat doleus muscle in ewsponse to high-fat diets. Am J Physiol 279: E1374-E1382
3 Steinberg GR, Parolin MI, Higenhauser GJ, Dyck DJ (2002): leptin increase FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283: E187-E192   DOI
4 Steinberg GR, Smith AC, van Denderen BJW, Chen Z, Murthy S, Campbell DJ, Heigenhauser GJF, Dyck DJ, Kemp BE (2004): AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J Clin Endocrinol Metab 89: 4575-4580   DOI   ScienceOn
5 Vettor R, Milan G, Rossato M, Federspil G (2005): Review article: adipocytokines and insulin resistance. Aliment Pharmacol Ther 22(2): 3-10   DOI
6 Westerterp-Plantenga MS, Saris WH, Hukshorn CJ, Campfield LA (2001): Effects of weekly administration opegylated recombinant human Ob protein on appetite profile and energy metabolism in obese men. Am J Clin Nutr 74: 426-434   DOI
7 World Health Organization (1998): Obesity: preventing and managing the global epidemic-report of a who consultation on obesity. pp.7-12, Geneva
8 Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman Ml, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T (2001): The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7(8): 941-946   DOI   ScienceOn
9 Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S (2003): Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52(10): 1274-1278   DOI   ScienceOn
10 Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (2000): Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 314(2): 1296-1301
11 Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M (2003): Markers of inflammation and cardiovascular disease: Application to clinical and public health practice:A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107(3): 499-511   DOI   ScienceOn
12 Pi-Sunyer FX (1993): Medical hazards of oesity. Ann Intern Med 119(2): 655-660   DOI
13 Rahmouni K, Haynes WG (2004): Leptin and the cardiovascular system. Recent Prog Horm Res 59(1): 225-244   DOI   ScienceOn
14 Ridker PM, Buring JE, Cook NR, Rifai N (2003): C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107(3): 391-397   DOI   ScienceOn
15 Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y, Funahashi T (2004): Adiponectin as a biomarker of the metabolic syndrome. Circ J 68(11): 975-981   DOI   ScienceOn
16 Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ (2002): Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87(12): 5662-5667   DOI   ScienceOn
17 Mattews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985): Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7): 412-419   DOI   ScienceOn
18 Ministry of Health and Welfare (2008): 2007 National health and nutrition survey report
19 Ministry of Health and Welfare (2009): 2008 National health and nutrition survey report
20 Muoio DM, Dohm GL (2002): Peripheral metabolic actions of leptin. Best Pract Res Clin Endocrinol Metab 16(4): 653-66   DOI   ScienceOn
21 Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, Hiuge A, Hibuse T, Ryo M, Nishizawa H, Maeda N, Maeda K, Shibata R, Walsh K, Funahashi T, Shimomura I (2006): Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47(6): 1108-1116   DOI   ScienceOn
22 Matsubara M, Maruoka S, Katayose S (2002): Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87(6): 2764-3769   DOI   ScienceOn
23 Lee MY, Kim JH (2010): Association of serum lipids and dietary intakes with serum adiponectin level in overweight and obese Korean Women. Korean J Community Nutr 15(1): 27-35
24 Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y (2002): Adiponectin in essential hypertension. J Nephrol 15(5): 507-511
25 Mantzoros CS, Williams CJ, Manson JE, Meigs JB, Hu FB (2006): Adherence to the mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr 84(2): 328-335
26 Matsuzawa Y, Funahashi T, Kihara S, Shimomura I (2004): Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24(1): 29-33   DOI   ScienceOn
27 Kim JI (2010): The association between hs-CRP concentration of blood and metabolic syndrome in the residents of rural community. Korean J Community Nutr 15(6): 796-805
28 Matsuzawa Y (2010): Establishment of a concept of visceral fat syndrome and discovery of adiponectin. Proc Jpn Acad 86: 131-140
29 Kadowaki T, Yamauchi T (2005): Adiponectin and adiponectin receptors. Endocrine Reviews 26(3): 439-451   DOI   ScienceOn
30 Kappes A, Loffler G (2000): Influences of ionomycin, dibutyrylcyclo AMP and tumor necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Horm Metab Res 32(11): 548-554   DOI
31 Kim JY, Shin HW, Jeong IK, Cho SW, Min SJ, Lee SJ, Park CY, Oh KW, Kim HK, Kim DM, Yu JM, Ihm SH, Choi MG, Yoo HJ, Park SW (2005): The relationship of adiponectin, leptin and ghrelin to insulin resistance and cardiovascular risk factors in human obesity. Korean J Med 69(6): 631-641
32 Hsueh WA, Buchanan TA (1994): Obesity and hypertension. Endocrinol Metab Clin North Am 23(2): 405-427
33 Koner A, Kratzsch J, Gausche R, Schaab M, Erbs S, Kiess W (2007): New predictors of the metabolic syndrome in children role of adipocytokines. Pediatr Res 61(6): 640-645   DOI   ScienceOn
34 Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y (2003): Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23(1): 85-89   DOI   ScienceOn
35 Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y (2001): Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50(5): 1126-1133   DOI   ScienceOn
36 Hulthe J, Hulten LM, Fagerberg B (2003): Low adipocytederived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism 52(12): 1612-1614   DOI   ScienceOn
37 Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE, Slentz CA, Sinha MK, Pories WJ, MacDonald KG, Dohm GL (2002): Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283(4): 861-865   DOI
38 Funahashi T, Nakamura T, Shimomura I, Maeda K, Kuriyama H, Takahashi M, Arita Y, Kihara S, Matsuzawa Y (1999): Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 38(2): 202-206   DOI   ScienceOn
39 Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T (2004): Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43(6): 1318-1323   DOI   ScienceOn
40 Jo HS, Baek YH (2006): Effects of combined exercise and green tea intake on body weight and adiponectin in obese high school children. Korean J Life Science 16(6): 972-977   DOI
41 Gannage-Yared MH, Khalife S, Semaan M, Fares F, Jambert S, Halaby G (2006): Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol 155: 167-176   DOI   ScienceOn
42 Galic S, Oakhill JS, Steinberg GR (2010): Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316: 129-139   DOI   ScienceOn
43 Corbetta S, Bulfamante G, Cortelazzi D, Barresi V, Cetin I, Mantovani G, Bondioni S, Beck-Peccoz P, Spada A (2005): Adiponectin expression in human fetal tissues during mid- and late gestation. J Clin Endocrinol Metab 90(4): 2397-2402   DOI   ScienceOn
44 Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kuschner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M (1999): Recombinant leptin for weight loss in obese and lean adults: a randomized, controllrd, dose-escalation trial. JAMA 282: 1568-1575   DOI   ScienceOn
45 Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y (2000): Plasma concentration of a novel adipose specific protein adiponectin in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20(6): 1595-1599   DOI   ScienceOn
46 Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR (1996): Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334(5): 292-295   DOI   ScienceOn
47 Diez JJ, Iglesias P (2003): The role of the novel adipocytederived hormone adiponectin in human disease. Eur J Endocrinol 148(3): 293-300   DOI   ScienceOn
48 Friedewald WT, Levy RI, Fredrickson DS (1972): Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6): 499-502
49 Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, Mohlig M, Pfeiffer AF, Luft FC, Sharma AM (2003): Association between adiponectin and mediators of inflammation in obese women. Diabetes 52(4): 942-947   DOI   ScienceOn
50 Fasshauer M, Paschke R (2003): Regulation of adipocytokines and insulin resistance. Diabetologia 46(12): 1594-1603   DOI   ScienceOn
51 Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y (2003): Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16(1):72-75   DOI   ScienceOn
52 Ahn GH, Kim SH, Yoo EG (2008): The relationship between leptin adiponectin ratio and insulin resistance in healthy children. Korean J Pediatr 51(3): 256-261   DOI   ScienceOn
53 Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B (2006): Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17(1): 4-12
54 Abbasi F, Chang SA, Chu JW, Ciaraldi TP, Lamendola C, McLaughlin T, Reaven GM, Reaven PD (2006) : Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol 290(1): 139-144   DOI
55 Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001): The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7(8): 947-953   DOI   ScienceOn
56 Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH (2004): Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol (Oxf) 61(1): 75-80
57 Clement K, Vaisse C, Lahlou N (1998): A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392(10): 398-401   DOI